176 related articles for article (PubMed ID: 21994129)
1. Dickkopf 4 positively regulated by the thyroid hormone receptor suppresses cell invasion in human hepatoma cells.
Liao CH; Yeh CT; Huang YH; Wu SM; Chi HC; Tsai MM; Tsai CY; Liao CJ; Tseng YH; Lin YH; Chen CY; Chung IH; Cheng WL; Chen WJ; Lin KH
Hepatology; 2012 Mar; 55(3):910-20. PubMed ID: 21994129
[TBL] [Abstract][Full Text] [Related]
2. Thyroid hormone receptor inhibits hepatoma cell migration through transcriptional activation of Dickkopf 4.
Chi HC; Liao CH; Huang YH; Wu SM; Tsai CY; Liao CJ; Tseng YH; Lin YH; Chen CY; Chung IH; Wu TI; Chen WJ; Lin KH
Biochem Biophys Res Commun; 2013 Sep; 439(1):60-5. PubMed ID: 23958302
[TBL] [Abstract][Full Text] [Related]
3. Dickkopf 4 (DKK4) acts on Wnt/β-catenin pathway by influencing β-catenin in hepatocellular carcinoma.
Fatima S; Lee NP; Tsang FH; Kolligs FT; Ng IO; Poon RT; Fan ST; Luk JM
Oncogene; 2012 Sep; 31(38):4233-44. PubMed ID: 22249261
[TBL] [Abstract][Full Text] [Related]
4. Proliferation and migration mediated by Dkk-1/Wnt/beta-catenin cascade in a model of hepatocellular carcinoma cells.
Qin X; Zhang H; Zhou X; Wang C; Zhang H; Zhang X; Ye L
Transl Res; 2007 Nov; 150(5):281-94. PubMed ID: 17964517
[TBL] [Abstract][Full Text] [Related]
5. Cathepsin H regulated by the thyroid hormone receptors associate with tumor invasion in human hepatoma cells.
Wu SM; Huang YH; Yeh CT; Tsai MM; Liao CH; Cheng WL; Chen WJ; Lin KH
Oncogene; 2011 Apr; 30(17):2057-69. PubMed ID: 21217776
[TBL] [Abstract][Full Text] [Related]
6. Sorafenib down-regulates expression of HTATIP2 to promote invasiveness and metastasis of orthotopic hepatocellular carcinoma tumors in mice.
Zhang W; Sun HC; Wang WQ; Zhang QB; Zhuang PY; Xiong YQ; Zhu XD; Xu HX; Kong LQ; Wu WZ; Wang L; Song TQ; Li Q; Tang ZY
Gastroenterology; 2012 Dec; 143(6):1641-1649.e5. PubMed ID: 22922424
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-122 suppresses cell proliferation and induces cell apoptosis in hepatocellular carcinoma by directly targeting Wnt/β-catenin pathway.
Xu J; Zhu X; Wu L; Yang R; Yang Z; Wang Q; Wu F
Liver Int; 2012 May; 32(5):752-60. PubMed ID: 22276989
[TBL] [Abstract][Full Text] [Related]
8. Epigenetic inactivation of the canonical Wnt antagonist secreted frizzled-related protein 1 in hepatocellular carcinoma cells.
Wu Y; Li J; Sun CY; Zhou Y; Zhao YF; Zhang SJ
Neoplasma; 2012; 59(3):326-32. PubMed ID: 22296502
[TBL] [Abstract][Full Text] [Related]
9. Dickkopf-4 is frequently down-regulated and inhibits growth of colorectal cancer cells.
Baehs S; Herbst A; Thieme SE; Perschl C; Behrens A; Scheel S; Jung A; Brabletz T; Göke B; Blum H; Kolligs FT
Cancer Lett; 2009 Apr; 276(2):152-9. PubMed ID: 19059704
[TBL] [Abstract][Full Text] [Related]
10. Downregulation of p57 accelerates the growth and invasion of hepatocellular carcinoma.
Guo H; Lv Y; Tian T; Hu TH; Wang WJ; Sui X; Jiang L; Ruan ZP; Nan KJ
Carcinogenesis; 2011 Dec; 32(12):1897-904. PubMed ID: 22002319
[TBL] [Abstract][Full Text] [Related]
11. Thyroid hormone receptors suppress pituitary tumor transforming gene 1 activity in hepatoma.
Chen RN; Huang YH; Yeh CT; Liao CH; Lin KH
Cancer Res; 2008 Mar; 68(6):1697-706. PubMed ID: 18339849
[TBL] [Abstract][Full Text] [Related]
12. Glucose induced activation of canonical Wnt signaling pathway in hepatocellular carcinoma is regulated by DKK4.
Chouhan S; Singh S; Athavale D; Ramteke P; Pandey V; Joseph J; Mohan R; Shetty PK; Bhat MK
Sci Rep; 2016 Jun; 6():27558. PubMed ID: 27272409
[TBL] [Abstract][Full Text] [Related]
13. Mammalian target of rapamycin regulates expression of β-catenin in hepatocellular carcinoma.
Feng Z; Fan X; Jiao Y; Ban K
Hum Pathol; 2011 May; 42(5):659-68. PubMed ID: 21239045
[TBL] [Abstract][Full Text] [Related]
14. Block of proliferation 1 (BOP1) plays an oncogenic role in hepatocellular carcinoma by promoting epithelial-to-mesenchymal transition.
Chung KY; Cheng IK; Ching AK; Chu JH; Lai PB; Wong N
Hepatology; 2011 Jul; 54(1):307-18. PubMed ID: 21520196
[TBL] [Abstract][Full Text] [Related]
15. Wnt signaling and hepatocarcinogenesis: molecular targets for the development of innovative anticancer drugs.
Pez F; Lopez A; Kim M; Wands JR; Caron de Fromentel C; Merle P
J Hepatol; 2013 Nov; 59(5):1107-17. PubMed ID: 23835194
[TBL] [Abstract][Full Text] [Related]
16. β-catenin plays a key role in metastasis of human hepatocellular carcinoma.
Lai TY; Su CC; Kuo WW; Yeh YL; Kuo WH; Tsai FJ; Tsai CH; Weng YJ; Huang CY; Chen LM
Oncol Rep; 2011 Aug; 26(2):415-22. PubMed ID: 21617877
[TBL] [Abstract][Full Text] [Related]
17. Suppression of actopaxin impairs hepatocellular carcinoma metastasis through modulation of cell migration and invasion.
Ng L; Tung-Ping Poon R; Yau S; Chow A; Lam C; Li HS; Chung-Cheung Yau T; Law WL; Pang R
Hepatology; 2013 Aug; 58(2):667-79. PubMed ID: 23504997
[TBL] [Abstract][Full Text] [Related]
18. Identification of naturally occurring dominant negative mutants of thyroid hormone alpha 1 and beta 1 receptors in a human hepatocellular carcinoma cell line.
Lin KH; Zhu XG; Shieh HY; Hsu HC; Chen ST; McPhie P; Cheng SY
Endocrinology; 1996 Oct; 137(10):4073-81. PubMed ID: 8828459
[TBL] [Abstract][Full Text] [Related]
19. Thyroid hormone receptor represses miR-17 expression to enhance tumor metastasis in human hepatoma cells.
Lin YH; Liao CJ; Huang YH; Wu MH; Chi HC; Wu SM; Chen CY; Tseng YH; Tsai CY; Chung IH; Wu TI; Tsai MM; Lin CD; Lin KH
Oncogene; 2013 Sep; 32(38):4509-18. PubMed ID: 23912452
[TBL] [Abstract][Full Text] [Related]
20. RASSF1A expression inhibits the growth of hepatocellular carcinoma from Qidong County.
Xue WJ; Li C; Zhou XJ; Guan HG; Qin L; Li P; Wang ZW; Qian HX
J Gastroenterol Hepatol; 2008 Sep; 23(9):1448-58. PubMed ID: 17683489
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
